Most patients in the control group received other GLP-1 drugs such as semaglutide, which Novo Nordisk sells for diabetes as ...

A total of 16.28% of patients with COVID-19 have developed postacute sequelae (PASC), or long-term symptoms that develop weeks or months after an infection. That is according to a May investigation ...

A Mount Sinai-led research team has demonstrated that autoimmunity, in which the body's immune system attacks its own tissues ...

Surpass-Early randomized ~800 adults with ≤4-year type 2 diabetes on metformin to add tirzepatide or intensify care, predominantly with semaglutide or dulaglutide comparators. At two years, ...

Patients with systemic autoimmune rheumatic disease demonstrate an increased persistence of SARS-CoV-2 antigen positivity up ...

Long COVID is a serious, growing public health crisis. Though estimates vary, as many as 18 million Americans may be affected. This is why it continues to capture the attention of Senator Todd Young, ...

Long COVID refers to symptoms that continue for three months or longer after the initial COVID-19 infection. Common symptoms ...

A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long COVID when administered outside of an infection. Administration of Paxlovid ...

Given that nearly everyone in the United States is believed to have had COVID, the 16 percent rate extrapolated to the ...

A possible first case of COVID recurrence after ensitrelvir: a vaccinated woman whose antigen levels fall and then rebound, with symptoms returning 1 day after treatment.